Industry News
WA's Colltech goes for IPO on the sheep's back
Western Australian company CollTech is aiming to raise up to AUD$5 million in its IPO to build a collagen extraction and purification facility, based on its novel and proprietary method for extracting the protein from sheep skins. [ + ]
AusBiotech hails 'exceptional' talent in new board line-up
AusBiotech members have elected Johnson & Johnson Research managing director Susan Pond, venture capitalist Leigh Farrell and former Amrad managing director Sandra Webb as corporate directors to its board, after a tight race between nine candidates. Western Australian Biomedical Research Institute director Simon Carroll was also re-elected as an institutional director. [ + ]
Why apomixis is genetic gold
They seek it here, they seek it there, but it remains hidden in the genetic thickets of flowering and seed development. A place in history awaits its finder. [ + ]
Bionomics signs with US ally
Adelaide biotechnology company Bionomics (ASX:BNO, US OTC:BMICY) has found a friendly American bloodhound to help it track down new genes involved in epilepsy -- the Brigham and Women's Hospital in Boston. [ + ]
Arnotts crumbles in face of anti-GM action
Leading Australasian biscuit manufacturer Arnotts has reacted to the threat of a consumer demonstration against its products in New Zealand by renewing its commitment to avoid the use of GM ingredients. [ + ]
Chemeq earns new patents, readies for Feb production
Perth-based pharmaceutical company Chemeq (ASX:CMQ) has announced that patents on its polymeric molecules to control microbial diseases in livestock have been approved in the US, Europe, Eurasia and China. [ + ]
Virax takes hep B compound into pre-clinical phase
Melbourne therapeutic vaccine company Virax (ASX:VHL) has taken its hepatitis B treatment into the pre-clinical development phase. [ + ]
TGR wins dairy research grant
Adelaide company TGR Biosciences has received a grant from the Gardiner Foundation to look for bioactives in milk. [ + ]
Gradipore raises $2.7m
Gradipore (ASX: GDP) has raised AUD$2.7 million in a placement of six million shares at $0.45 to institutional investors. [ + ]
International work on high blood pressure
A groundbreaking international collaboration is quietly underway at The University of New South Wales.
[ + ]Deakin Uni haptics has the right touch
Parents visiting the doctor for an ultrasound of their unborn baby will be able to 'touch' as well as see their baby with new technology being developed at Deakin University.
[ + ]Light factories: going one better than nature
Researchers are attempting to perfect photosynthesis, a process pioneered by plants and bacteria, in an ambitious scheme to generate new foods, fabrics and even electricity, sustainably.
[ + ]Leap frogging in muscle research
Can a frog that is known to bury itself in mud for months on end hold the key to avoiding muscle wastage in people with broken bones?
[ + ]Genome solved -- hunt for vaccine targets begins
The genes of a bacterium that can kill or cause permanent organ damage in humans have been identified by Monash University researchers, whose efforts are now focused on finding a suitable vaccine.
[ + ]Swinburne IT students create innovative software
Swinburne TAFE information technology students have created a range of innovative software packages. Two of the packages will influence communications within the Australian Department of Defence and assist in vital research being conducted at Monash University into the structure of proteins.
[ + ]